Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $353.96 million. The enterprise value is $468.48 million.

Market Cap	353.96M
Enterprise Value	468.48M

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

GALT has 64.47 million shares outstanding. The number of shares has increased by 2.12% in one year.

Current Share Class	64.47M
Shares Outstanding	64.47M
Shares Change (YoY)	+2.12%
Shares Change (QoQ)	+1.19%
Owned by Insiders (%)	20.33%
Owned by Institutions (%)	16.37%
Float	45.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.10

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-87.09%
Return on Invested Capital (ROIC)	-213.11%
Return on Capital Employed (ROCE)	23.59%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +188.19% in the last 52 weeks. The beta is 0.96, so GALT's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+188.19%
50-Day Moving Average	5.34
200-Day Moving Average	3.19
Relative Strength Index (RSI)	47.98
Average Volume (20 Days)	431,454

Short Selling Information

The latest short interest is 6.76 million, so 10.48% of the outstanding shares have been sold short.

Short Interest	6.76M
Short Previous Month	6.90M
Short % of Shares Out	10.48%
Short % of Float	14.79%
Short Ratio (days to cover)	17.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.15M
Pretax Income	-37.30M
Net Income	-37.44M
EBITDA	n/a
EBIT	-29.15M
Earnings Per Share (EPS)	-$0.59

Balance Sheet

The company has $11.53 million in cash and $126.05 million in debt, giving a net cash position of -$114.53 million or -$1.78 per share.

Cash & Cash Equivalents	11.53M
Total Debt	126.05M
Net Cash	-114.53M
Net Cash Per Share	-$1.78
Equity (Book Value)	-123.58M
Book Value Per Share	-1.95
Working Capital	-123.72M

Cash Flow

Operating Cash Flow	-30.62M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.12%
Shareholder Yield	-2.12%
Earnings Yield	-10.58%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $6.00, which is 9.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	9.29%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1